Haemonetics Corporation‘s (HAE) shares have increased 10.8% year to date compared with the industry’s rise of 6.1%. The Medical sector has gained 1% in the said time frame. The company has a market capitalization of $4.82 billion. The consistent growth performance in the past few quarters, reflecting its strategic focus on establishing leading positions in high-growth markets to generate solid financial returns, is likely to drive this Zacks Rank 1 (Strong Buy) stock. Its earnings are expected to grow 12% i ...